CRYO CELL INTERNATIONAL INC
For the period ended May 31, 2025. Filed Jul 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
May 31, 2025 · Filed Jul 15, 2025
CCEL$4.87-0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Deficit
| Additional · Total | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Paid-In · Treasury · Accumulated · Stockholders' | |||||||
| Shares · Amount · Capital · Stock · Deficit · Deficit | |||||||
| Balance at February 28, 2025 | 14,849,619 | $148,696 | $44,565,861 | $(24,855,556) | $(34,515,310) | $(14,656,309) | |
| Compensatory element of stock options | 40,026 | $40,026 | |||||
| Treasury stock | (88,619) | (88,619) | |||||
| Dividends declared ($0.15 per share) | (1,210,688) | (1,210,688) | |||||
| Net income | 355,785 | $355,785 | |||||
| Balance at May 31, 2025 | 14,849,619 | $148,696 | $44,605,887 | $(24,944,175) | $(35,370,213) | $(15,559,805) | |
| Additional · Total | |||||||
| Common Stock · Paid-In · Treasury · Accumulated · Stockholders' | |||||||
| Shares · Amount · Capital · Stock · Deficit · Deficit | |||||||
| Balance at November 30, 2024 | 14,849,619 | $148,696 | $44,268,469 | $(24,855,556) | $(32,777,626) | $(13,216,017) | |
| Compensatory element of stock options | 337,418 | 337,418 | |||||
| Treasury stock | (88,619) | (88,619) | |||||
| Dividends declared ($0.40 per share) | (3,231,227) | (3,231,227) | |||||
| Net income | 638,640 | 638,640 | |||||
| Balance at May 31, 2025 | 14,849,619 | $148,696 | $44,605,887 | $(24,944,175) | $(35,370,213) | $(15,559,805) | |
| Additional · Total | |||||||
| Common Stock · Paid-In · Treasury · Accumulated · Stockholders' | |||||||
| Shares · Amount · Capital · Stock · Deficit · Deficit | |||||||
| Balance at February 29, 2024 | 14,849,246 | $148,492 | $43,718,498 | $(23,602,061) | $(30,602,941) | $(10,338,012) | |
| Compensatory element of stock options | 178,139 | 178,139 | |||||
| Treasury stock | (1,237,095) | (1,237,095) | |||||
| Net income | 655,790 | 655,790 | |||||
| Balance at May 31, 2024 | 14,849,246 | $148,492 | $43,896,637 | $(24,839,156) | $(29,947,151) | $(10,741,178) | |
| Additional · Total | |||||||
| Common Stock · Paid-In · Treasury · Accumulated · Stockholders' | |||||||
| Shares · Amount · Capital · Stock · Deficit · Deficit | |||||||
| Balance at November 30, 2023 | 14,849,246 | $148,492 | $43,411,143 | $(23,431,685) | $(31,159,182) | $(11,031,232) | |
| Compensatory element of stock options | 485,494 | 485,494 | |||||
| Treasury stock | (1,407,471) | (1,407,471) | |||||
| Net income | 1,212,031 | 1,212,031 | |||||
| Balance at May 31, 2024 | 14,849,246 | $148,492 | $43,896,637 | $(24,839,156) | $(29,947,151) | $(10,741,178) | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.